Skip to content

Study the effects of anti-inflammatory capsules (containing three of ginger, turmeric and black pepper) in patients with active rheumatoid arthritis

Study the effects of anti-inflammatory capsules (containing three of ginger, turmeric and black pepper) in 60 patients with active rheumatoid arthritis according to DAS28 criteria

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016112530817N1
Enrollment
60
Registered
2017-01-07
Start date
2015-07-27
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis. Rheumatoid arthritis, unspecified

Interventions

Intervention 1: The intervention group for 8 weeks receive anti-inflammatory capsules (containing three of ginger, turmeric and black pepper)2 times a day. Intervention 2: The control group received p
Treatment - Drugs
Placebo
The intervention group for 8 weeks receive anti-inflammatory capsules (containing three of ginger, turmeric and black pepper)2 times a day
The control group received placebo for 8 weeks to receive 2 times a day

Sponsors

Vice President of Research Jondishapour University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age over 18 years old and people with rheumatoid arthritis. Exclusion criteria: age under 18 years old; disease duration more than 5 years; pregnancy; cancer.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
DAS28. Timepoint: The first blood before the onset of drug use to be. Then the end of 8 weeks, blood samples were taken at the end of the intervention. Method of measurement: Through the blood.

Secondary

MeasureTime frame
CRP. Timepoint: The first blood before the onset of drug use to be. Then the end of 8 weeks, blood samples were taken at the end of the intervention. Method of measurement: Through the blood.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ali Asghar Hemmati

Ahwaz Jondi Shapour University of Medical Sciences

hemmati-aa@ajums.ac.ir+98 61 3373 8382

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026